Parallel reaction monitoring (PRM) is a targeted quantification method on high-resolution mass spectrometers: scheduled precursors are isolated, fragmented, and recorded as full MS2 spectra so quantitative and qualifier fragments can be extracted after acquisition (Peterson et al. 2012). Used comprehensively, PRM confirms a closed peptide panel with accurate-mass ion review, optional stable isotope-labeled standards for absolute amount, and matched prep plus retention-time scheduling under declared QC. It does not survey an open proteome like DDA or DIA, and ordinary fragment areas remain relative without calibration (Lange et al. 2008). Prefer PRM when nominated targets need high-resolution confirmation; prefer MRM for mature high-multiplex transition panels; keep discovery open when the inventory is still changing.
Researchers who already have a closed peptide panel or a validation objective can also review the MtoZ Biolabs Parallel Reaction Monitoring (PRM) Service and Targeted Proteomics Service for project-specific feasibility and assay planning.
Comprehensive View of PRM Targeted Quantification
PRM answers a closed-list quantitative question. The comprehensive package combines peptide selection, scheduling, fragment extraction, and a declared relative or absolute claim.
Component |
Role in targeted quantification |
Limit if ignored |
|---|---|---|
Closed proteotypic panel |
Defines what can be measured |
Unscheduled proteins are invisible |
Matched digestion and cleanup |
Keeps peptide recovery comparable |
Prep drift looks like biology |
Retention-time scheduling |
Fits precursors into chromatographic cycle time |
Overpacking destabilizes peak areas |
Full high-resolution MS2 |
Stores fragments for post-run quant and qualifiers |
Isolation-window co-fragmentation can remain |
Relative readout |
Same-peptide areas across groups |
Not molar concentration |
Optional SIS / AQUA |
Places selected peptides on an amount scale |
Requires reserved material and calibration |
Figure 1. PRM targeted quantification is a scheduled closed-panel method: full MS2 enables fragment review, while the claim stays relative unless standards are added.
Calling PRM highly specific without stating panel closure, isolation width, and relative-versus-absolute design overstates the method name alone.
How PRM Quantifies Versus MRM and Discovery Routes
Route |
What is recorded |
Typical targeted-quant fit |
|---|---|---|
PRM |
Scheduled precursor; full HR MS2; post-run fragment choice |
Confirmation in complex digests; panel still being refined |
MRM / SRM |
Predefined Q1-Q3 transitions on a triple quadrupole |
Mature, high-multiplex transition panels |
DIA / LFQ discovery |
Open or semi-open relative inventories |
Nominate candidates before PRM |
PRM improves post-acquisition fragment flexibility relative to MRM. It does not recreate DIA discovery coverage. Adding peptides still consumes cycle time and must be re-scheduled.
Figure 2. PRM and MRM both quantify closed panels; they differ mainly in recorded ions, multiplex efficiency, and fragment-review flexibility.
For principle-level framing, see Principles of PRM Quantitative Proteomics. For operational workflow, see Parallel Reaction Monitoring (PRM): Principles, Workflow, and Applications. For PRM versus MRM selection, see PRM vs MRM: Comparative Analysis in Quantitative Proteomics and PRM and MRM in Targeted Proteomics: Advantages and Limitations. For validation study planning, see How to Plan a Targeted Proteomics Validation Study.
Judgment Criteria: When PRM Targeted Quantification Fits
Study need |
PRM often fits |
Reassess before scheduling |
|---|---|---|
Inventory |
Candidates already reduced to proteotypic peptides |
Open discovery list still expanding |
Evidence need |
Accurate-mass fragment review in complex matrices |
Only a locked triple-quadrupole panel is available |
Panel size |
Short to moderate list within cycle-time budget |
Multiplex demand exceeds chromatographic sampling |
Claim |
Relative confirmation, or absolute with SIS planned |
Amount required without standards or calibrators |
Upstream data |
DDA or DIA already nominated usable peptides |
No matrix pilot evidence yet |
Prefer PRM when high-resolution confirmation of a closed panel is the priority. Prefer MRM when transitions are mature and throughput on a triple quadrupole dominates. Prefer DIA or LFQ when the inventory must stay open. Prefer AQUA-style SIS designs when concentration units are required on a shortlist.
Figure 3. Use PRM for closed-panel high-resolution quantification; change route when multiplex maturity, open discovery, or absolute standards dominate.
For absolute unit design, see Absolute Quantification in Targeted Proteomics and AQUA Proteomics. For MRM or SRM context, see SRM Mass Spectrometry and Principle of Multiple Reaction Monitoring.
Limits and Application Boundaries
PRM does not quantify unscheduled proteins. Full MS2 storage does not erase isolation-window co-fragmentation. Overpacked schedules reduce points across chromatographic peaks. Relative fragment areas are not molar concentrations without matched standards and calibration. Protein inference still depends on surrogate peptide behavior and digestion consistency. Pathway enrichment on a confirmed shortlist reflects that panel, not whole-proteome pathway proof.
Typical applications:
- Biomarker-candidate confirmation after discovery screening.
- Pathway or pharmacodynamic panels across treatment arms.
- Discovery follow-up when DIA or LFQ hits need high-resolution peptide evidence.
- Biopharmaceutical or comparability peptide monitoring in complex matrices.
- Selected PTM-site checks when modified surrogates can be defended.
- Interference recovery when unit-resolution MRM transitions are unstable.
Diagnostic cutoffs and companion-diagnostic claims sit outside ordinary research PRM reporting unless a separately validated assay framework is in place.
Once the peptide list, relative-versus-absolute claim, and scheduling budget are defined, the project can be scoped as PRM targeted quantification. Researchers can review the MtoZ Biolabs Parallel Reaction Monitoring (PRM) Service for sample evaluation and assay planning. For MRM service options, see SRM-MRM Quantitative Proteomics Services.
Frequently Asked Questions
1. What is PRM used for in targeted quantification?
Selective quantification of a predefined peptide panel on high-resolution instruments, using extracted fragment chromatograms from full MS2 spectra.
2. How does PRM differ from MRM for quantification?
MRM monitors predefined transitions during acquisition. PRM stores full high-resolution MS2 and allows post-run fragment choice.
3. Can PRM provide absolute quantification?
Yes, when matched SIS peptides and calibration are included. Otherwise the default claim is relative.
4. How large can a PRM panel be?
Only as large as chromatography and cycle time allow. Over-multiplexing weakens quantitative precision even on high-resolution instruments.
5. Should PRM replace DIA discovery?
No. DIA or LFQ nominates candidates. PRM confirms a closed shortlist with scheduled acquisition.
Reference
- A.C. Peterson, J.D. Russell, D.J. Bailey, M.S. Westphall, J.J. Coon (2012). Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Mol. Cell. Proteomics, 11, 1475-1488. https://doi.org/10.1074/mcp.O112.020131
- V. Lange, P. Picotti, B. Domon, R. Aebersold (2008). Selected reaction monitoring for quantitative proteomics: a tutorial. Mol. Syst. Biol., 4, 222. https://doi.org/10.1038/msb.2008.61
